Senegal-made sickle cell treatment raises hopes, reduces costs
Mamadou Tahirou is 18 but looks more like a 12-year-old; his frame is frail from the ravages of sickle cell disease, which one Senegalese laboratory is hoping to attenuate with affordable drug production. The lab is one of the few in Africa producing generic hydroxyurea, the gold standard in sickle cell treatment, and the first Read More: https://punchng.com/senegal-made-sickle-cell-treatment-raises-hopes-reduces-costs/